Iowa Research Online
Works
IRO Home
Research units
Researcher Profiles
About IRO
Sign in
Back
Thesis
Open access
The role of MYD88-dependent receptors in the anti-tumor efficacy of the EGFR inhibitor Erlotinib in head and neck cancer
Adam Taylor Koch
University of Iowa
Master of Science (MS), University of Iowa
Summer 2014
DOI: 10.17077/etd.huzxr92x
View
Share
Export
Files and links (1)
Abstract
Details
Metrics
Files and links (1)
pdf
The role of MYD88-dependent receptors in the anti-tumor efficacy
6.35 MB
Download
View
Free to read and download
, Open Access
Abstract
Pathology
EGFR
erlotinib
IL-1 alpha
IL-1 Receptor
MyD88
TLR5
Details
Title: Subtitle
The role of MYD88-dependent receptors in the anti-tumor efficacy of the EGFR inhibitor Erlotinib in head and neck cancer
Creators
Adam Taylor Koch - University of Iowa
Contributors
Andrean Simons-Burnett (Advisor)
Hasem Habelhah (Committee Member)
Weizhou Zhang (Committee Member)
Fayyaz Sutterwala (Committee Member)
Resource Type
Thesis
Degree Awarded
Master of Science (MS), University of Iowa
Degree in
Pathology
Date degree season
Summer 2014
Publisher
University of Iowa
DOI
10.17077/etd.huzxr92x
Number of pages
vii, 88 pages
Copyright
Copyright 2014 Adam Taylor Koch
Language
English
Description illustrations
illustrations (some color)
Description bibliographic
Includes bibliographical references (pages 78-88).
Academic Unit
Pathology
Record Identifier
9983777048502771
Show the rest
Metrics
396
File views/ downloads
97
Record Views
Browse by research and academic units
Browse and search our researcher profiles
The role of MYD88-dependent receptors in the anti-tumor efficacy